• Episode: 64 - Peyton Greenside on AI’s Role in Antibody Engineering, Optimization, and More

  • Aug 13 2024
  • Duración: 33 m
  • Podcast

Episode: 64 - Peyton Greenside on AI’s Role in Antibody Engineering, Optimization, and More

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode of The Chain, host Nimish Gera, Ph.D., vice president of biologics at Mythic Therapeutics, speaks with Peyton Greenside, CSO and co-founder of BigHat Biosciences, about the role of AI and machine learning in antibody engineering and targeting complex modalities, including bispecifics and ADCs. Greenside also discusses the work her organization does, what BigHat is doing to ensure the quality of data to train their AI models with, the methods of approaching harder targets such as GPCRs, and certain properties that AI can optimize better.

    Más Menos
Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Episode: 64 - Peyton Greenside on AI’s Role in Antibody Engineering, Optimization, and More

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles